Terms: = Skin cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC
169 results:
1. Genetic Polymorphisms of xpc, XPD, XPG Genes and their Association with Radiotherapy Induced Toxicity among Head and Neck cancer Patients: A Hospital Based Study from Maharashtra.
Gudur AK; Kale SR; Gudur RA; Bhosale SJ; Datkhile KD
Asian Pac J Cancer Prev; 2024 Jan; 25(1):191-199. PubMed ID: 38285784
[TBL] [Abstract] [Full Text] [Related]
2. Mapping the recognition pathway of cyclobutane pyrimidine dimer in DNA by Rad4/xpc.
Jakhar N; Prabhakant A; Krishnan M
Nucleic Acids Res; 2023 Oct; 51(19):10132-10146. PubMed ID: 37757853
[TBL] [Abstract] [Full Text] [Related]
3. Successful treatment of non-melanoma skin cancer in three patients with Xeroderma Pigmentosum by modified ALA-PDT.
Zheng J; Liu W; Zhou Z; Cao Z; Zhao Z; Wang X; Li M; Zhang G
Photodiagnosis Photodyn Ther; 2023 Sep; 43():103694. PubMed ID: 37422200
[TBL] [Abstract] [Full Text] [Related]
4. Xenopus: An in vivo model for studying skin response to ultraviolet B irradiation.
El Mir J; Fedou S; Thézé N; Morice-Picard F; Cario M; Fayyad-Kazan H; Thiébaud P; Rezvani HR
Dev Growth Differ; 2023 May; 65(4):194-202. PubMed ID: 36880984
[TBL] [Abstract] [Full Text] [Related]
5. Recurrent squamous cell carcinoma and a novel mutation in a patient with xeroderma pigmentosum: a case report.
Şahin EA; Taşkıran EZ; Kiper PÖŞ; Aydın B; Utine E
J Med Case Rep; 2022 Jul; 16(1):306. PubMed ID: 35902966
[TBL] [Abstract] [Full Text] [Related]
6. Xeroderma Pigmentosum: A Genetic Condition skin cancer Correlated-A Systematic Review.
Brambullo T; Colonna MR; Vindigni V; Piaserico S; Masciopinto G; Galeano M; Costa AL; Bassetto F
Biomed Res Int; 2022; 2022():8549532. PubMed ID: 35898688
[TBL] [Abstract] [Full Text] [Related]
7. BAP1 promotes the repair of UV-induced DNA damage via PARP1-mediated recruitment to damage sites and control of activity and stability.
Lee SA; Lee D; Kang M; Kim S; Kwon SJ; Lee HS; Seo HR; Kaushal P; Lee NS; Kim H; Lee C; Kwon J
Cell Death Differ; 2022 Dec; 29(12):2381-2398. PubMed ID: 35637285
[TBL] [Abstract] [Full Text] [Related]
8. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.
Nikolaev S; Yurchenko AA; Sarasin A
Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173
[TBL] [Abstract] [Full Text] [Related]
9. Cutaneous Neurocristic Hamartoma Mimicking Basal Cell Carcinoma in a Patient With Xeroderma Pigmentosum.
Finberg A; Martin S; Gradecki S; Zlotoff B; Raghavan SS
Am J Dermatopathol; 2022 May; 44(5):e54-e56. PubMed ID: 35170472
[TBL] [Abstract] [Full Text] [Related]
10. Association of polymorphisms in nucleotide excision repair pathway genes with susceptibility to cutaneous melanoma.
Hashemzehi A; Ghadyani M; Asadian F; Dastgheib SA; Kargar S; Neamatzadeh H; Akbarian E; Emarati A
Klin Onkol; 2021; 34(5):350-355. PubMed ID: 34702042
[TBL] [Abstract] [Full Text] [Related]
11. Xeroderma Pigmentosum C: A Valuable Tool to Decipher the Signaling Pathways in skin cancers.
Nasrallah A; Fayyad N; Kobaisi F; Badran B; Fayyad-Kazan H; Fayyad-Kazan M; Sève M; Rachidi W
Oxid Med Cell Longev; 2021; 2021():6689403. PubMed ID: 34630850
[TBL] [Abstract] [Full Text] [Related]
12. Differences in peripheral neuropathy in xeroderma pigmentosum complementation groups A and D as evaluated by nerve conduction studies.
Lehky TJ; Sackstein P; Tamura D; Quezado M; Wu T; Khan SG; Patronas NJ; Wiggs E; Brewer CC; DiGiovanna JJ; Kraemer KH
BMC Neurol; 2021 Oct; 21(1):393. PubMed ID: 34627174
[TBL] [Abstract] [Full Text] [Related]
13. Mutagenicity Profile Induced by UVB Light in Human Xeroderma Pigmentosum Group C Cells.
Quintero-Ruiz N; Corradi C; Moreno NC; de Souza TA; Pereira Castro L; Rocha CRR; Menck CFM
Photochem Photobiol; 2022 May; 98(3):713-731. PubMed ID: 34516658
[TBL] [Abstract] [Full Text] [Related]
14. Isoconazole and Clemizole Hydrochloride Partially Reverse the Xeroderma Pigmentosum C Phenotype.
Kobaisi F; Sulpice E; Barette C; Fayyad N; Fauvarque MO; Badran B; Fayyad-Kazan M; Fayyad-Kazan H; Gidrol X; Rachidi W
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360928
[TBL] [Abstract] [Full Text] [Related]
15. xpc deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature.
Yurchenko AA; Padioleau I; Matkarimov BT; Soulier J; Sarasin A; Nikolaev S
Nat Commun; 2020 Nov; 11(1):5834. PubMed ID: 33203900
[TBL] [Abstract] [Full Text] [Related]
16. Molecular analysis directs the prognosis, management and treatment of patients with xeroderma pigmentosum.
Lehmann AR; Fassihi H
DNA Repair (Amst); 2020 Sep; 93():102907. PubMed ID: 33087273
[TBL] [Abstract] [Full Text] [Related]
17. Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients.
Aoude LG; Bonazzi VF; Brosda S; Patel K; Koufariotis LT; Oey H; Nones K; Wood S; Pearson JV; Lonie JM; Arneil M; Atkinson V; Smithers BM; Waddell N; Barbour AP
Sci Rep; 2020 Oct; 10(1):17687. PubMed ID: 33077847
[TBL] [Abstract] [Full Text] [Related]
18. Association of xpc Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
[TBL] [Abstract] [Full Text] [Related]
19. A novel missense variant and multiexon deletion causing a delayed presentation of xeroderma pigmentosum, group C.
Macke EL; Morales-Rosado JA; Gupta A; Schmitz CT; Kruisselbrink T; Lanpher B; Klee EW
Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843428
[TBL] [Abstract] [Full Text] [Related]
20. Rare exon 10 deletion in POLH gene in a family with xeroderma pigmentosum variant correlating with protein expression by immunohistochemistry.
Borroni RG; Diegoli M; Grasso M; Concardi M; Agozzino M; Vignini M; Arbustini E
G Ital Dermatol Venereol; 2020 Jun; 155(3):349-354. PubMed ID: 32635709
[TBL] [Abstract] [Full Text] [Related]
[Next]
